1 The present study was addressed to clarify the subtypes of P2-purinoceptor involved in ATP release and contraction evoked by a,b-methylene ATP (a,b-mATP) and other P2-agonists in guinea-pig ileum. 2 a,b-mATP 100 mM produced a transient and steep contraction followed by ATP release from tissue segments. These maximum responses appeared with dierent time-courses and their ED 50 values were 5 and 25 mM, respectively. The maximum release of ATP by a,b-mATP was markedly reduced by 250 mM suramin, 30 mM pyridoxal-phosphate-6-azophenyl-2',5'-disulphonic acid (PPADS) and 30 mM reactive blue 2 (RB-2), P2-receptor antagonists. However, the contractile response was inhibited by suramin, tetrodotoxin and atropine, but not by PPADS and RB-2. 3 Although the contraction caused by a,b-mATP was strongly diminished by Ca 2+ -removal and nifedipine, and also by tetrodotoxin and atropine at 0.3 mM, the release of ATP was virtually unaected by these procedures. 4 UTP, b,g-methylene ATP (b,g-mATP) and ADP at 100 mM elicited a moderate release of ATP. The release caused by UTP was virtually unaected by RB-2. However, these P2-agonists failed to elicit a contraction of the segment. 5 The potency order of all the agonists tested for the release of ATP was a,b-mATP4UTP4b,gmATP4ADP.
Introduction
On the basis of functional characteristics and potency order of agonists, P2-purinoceptors have been divided into six subtypes, P2X, P2Y, P2U, P2T, P2Z and P2D (Fredholm et al., 1994) . However, it is likely that neither agonists nor antagonists for the P2-receptor subtypes show speci®c eects.
Recent cloning studies presented evidence that P2X-receptors (ion channels) and P2Y-receptors (G-protein coupled) could be subclassi®ed into P2X 1 , P2X 2 ⋅ ⋅ ⋅ ⋅ ⋅ P2X 7 and P2Y 1 , P2Y 2 ⋅ ⋅ ⋅ ⋅ ⋅ P2Y 7 , respectively (Burnstock & King, 1996; Fredholm et al., 1997) . Evidence showing functional roles of these new subtypes has not yet been gathered. a,b-Methylene adenosine 5'-triphosphate (a,b-mATP) has long been accepted as a typical P2X-receptor agonist because the ATP analogue contracts smooth muscles, e.g., vas deferens of guinea-pig, and the evoked contraction is antagonized by suramin (Fredholm et al., 1994) . However, a,b-mATP has also been described as a weak P2Y-agonist (Satchell & Maguire, 1975; Fredholm et al., 1994) . Therefore, the relationship between the functions of this agonist and its selectivity for P2X-and P2Y-receptors deserves careful attention. In previous studies, we found that administration of a,b-mATP caused ATP release and contraction simultaneously in ileal longitudinal muscle segments of guineapigs (Katsuragi et al., 1991; 1992; . The evoked release of ATP was inhibited by phospholipase C inhibitors, e.g., spermine and neomycin, whereas, the contraction was virtually unaected . The ®ndings suggest that the release of ATP and the contraction evoked by a,b-mATP are mediated via dierent subtypes of P2-receptor. Accordingly, the present study was addressed to elucidate the receptors mediating these responses to a,b-mATP, uridine 5'-triphosphate (UTP) and other P2-agonists in intact and, in part, cultured smooth muscles from guinea-pig ileum.
Methods

Contraction and ATP release from tissue segments
Male guinea-pigs weighing 200 to 350 g were stunned and bled. The distal part (about 5 cm long) of the ileum was dissected 3 cm from the ileocaecum. The mucosal membranes including submucosal layers and circular muscles were mechanically removed from the longitudinal muscle layer as described previously (Katsuragi et al., 1990; . The longitudinal strip (3 by 30 mm) was suspended in a bath (1 ml) ®lled with Krebs solution (328C) of the following composition (mM): NaCl 122, KCl 5.2, CaCl 2 2.4, MgSO 4 1.2, NaHCO 3 25.6, D-glucose 11, Na 2 EDTA 0.03 and ascorbic acid 0.l, bubbled with 95% O 2 /5% CO 2 . After 0.5 g initial tension had been applied to the preparation, the isometric tension was monitored simultaneously on a polygraph with a force transducer (Toyo-Baldwin, T-7-8-240). The longitudinal muscle segment was allowed to equilibrate for 20 min, washed three times quickly with fresh solution and then was kept for a further 30 min in this solution. A control sample (50 ml) was taken 5 min before the end of the 50 min equilibration period.
Thereafter, aliquots (50 ml) as test samples were collected 3, 15 and 25 min after the addition of agonists. After every sampling, an equivalent volume of bubbled Krebs solution (328C) was added to the bath. At the end of the experiment, the segment was blotted with ®lter paper and weighed.
ATP release from cultured cells
The ileum was dissected from guinea-pigs of either sex within 2 days after birth. The longitudinal muscle segment was minced into small pieces (about 0.5 mm 3 ) in Dulbecco's phosphate buered saline supplemented with 0.25 mg ml 71 collagenase and kept at 48C overnight. After being kept in a 378C incubator for 40 min, the pellet was collected by centrifugation (180 g) for 3 min and transferred to a dish containing the phosphate buered saline with 0.062% trypsin. Following trituration, the content was transferred to a tube with 10% foetal calf serum and centrifuged for 5 min. The pellet was dispersed in a dish containing M-199 medium (Bodin et al., 1991) with foetal calf serum and the culture was started in the incubator (378C) supplied with CO 2 . The culture medium was not replaced with any other media during the culturing. After 5 to 7 days, the cell growth became con¯uent. Before use, the medium culturing the cells was replaced by 0.25% trypsin in phosphate buered saline and kept for 3 min at 378C. Fibroblast and other cells contaminating the smooth muscle cells were¯oated by a slight vibration and eliminated by enough rinsing with a fresh phosphate buered saline. The morphological purity of the smooth muscle cells and the lack of neuronal cells in a dish was microscopically determined. The cultured cells were trapped in a Millipore ®lter holder (Swinnex-25) and were perfused at 0.5 ml min 71 with the oxygenated Krebs solution (378C) by use of a peristaltic pump. After a 5 min equilibration period, the perfusate was collected every 90 s for 15 min. Then, an aliquot, 100 ml, was taken from a fraction medium for measurement of ATP.
The protein content of the smooth muscle cells was determined with the Bio-Rad protein assay kit II after an overnight incubation (48C) of the ®lter in deionized water containing 0.1% Triton X-100.
ATP measurement
In order to determine endogenous ATP, every sample of medium (50 or 100 ml) was treated with 100 ml of ATP assay solution (Lucifel-LU; Kikkoman, Noda, Japan). The intensity of light produced by the reaction was measured with a luminometer as described previously (Katsuragi et al., 1991; .
Treatments
Although we do not know whether uridine 5'-triphosphate (UTP) was contaminated with a trace of ATP or is a very weak substrate for the ®re¯y enzyme, UTP per se, unlike other P2-agonists tested, reacted slightly with luciferin-luciferase. Therefore, the values of ATP released by UTP were ®nally estimated by subtracting the small value found when the corresponding concentration of UTP was tested in tissue-free medium. When ATP was determined from a sample medium containing suramin, 250 ml of the ATP assay solution, i.e., a larger volume than that normally used, was applied because of interference by suramin with luciferase activities. Ca 2+ -free Krebs solution was prepared by removal of Ca 2+ from the solution and, by addition of 1 mM EGTA.
Drugs
The drugs used were: a,b-methylene ATP Li + salt, b,g-methylene ATP Na + salt, UTP Na + salt, ADP Na + salt, nifedipine, reactive blue-2 (Sigma, St. Louis, MO, U.S.A.), pyridoxal-phosphate-6-azophenyl-2',5'-disulphonic acid tetrasodium salt (PPADS) (Tocris Cookson, Bristol, U.K.) and suramin (gift from Bayer, Wuppertal, Germany).
Statistics
Dierence between multiple means was tested for statistical signi®cance by one way analysis of variance (ANOVA) followed by Dunnett's test. A value of P50.05 was considered to be signi®cant.
Results
In the ileal longitudinal muscles of guinea-pigs, a,b-methylene ATP (a,b-mATP, 100 mM), a stable ATP analogue, produced ATP release accompanying a transient and steep contraction as described previously (Katsuragi et al., 1991) . A concentration-response curve for ATP release by a,b-mATP was compared with its concentration-contractible response curve. The tissue was contracted by a,b-mATP in concentrations ranging from 0.1 to 100 mM, whereas ATP was released by the agonist in a narrow concentration range between 10 and 100 mM (Figure 1) . The ED 50 values of the contractile and release responses amounted to approximately 5 and 25 mM, respectively. Furthermore, the time-course of the contraction and the release of ATP evoked by 100 mM a,b-mATP was evaluated. The contraction culminated immediately after the administration of a,b-mATP. On the other hand, the release gradually reached its maximum level 2 ± 3 min after the administration of the drug, as described previously (Katsuragi et al., 1991; . The values for the basal and the maximum release of ATP were 18.32+1.44 pmol ml 71 g 71 wet weight (n=6) and 57.52+5.99 pmol ml 71 g 71 wet weight (n=26), respectively. The maximum release of ATP was markedly diminished by 250 mM suramin, a non-selective antagonist for P2X and P2Y receptors and 30 mM PPADS, a P2-antagonist. In addition, the release was also inhibited by 30 mM reactive blue 2 (RB-2, a P2Y-antagonist) (Figure 2a) . The contractile response to a,bmATP was usually monophasic, but occasionally a biphasic contraction was seen, as shown previously (Kennedy & Humphrey, 1994) . In the case of the biphasic contraction, an initial transient and large contraction followed by a slow contraction were observed. Thus, the amplitude of the response to the P2-agonist was determined from the transient large contraction in all cases. The evoked contraction was antagonized by 250 mM suramin, 0.3 mM tetrodotoxin and 0.3 mM atropine, but not by PPADS and RB-2 at 30 mM (Figures 2b and 3b) . Furthermore, the contraction was completely abolished by Ca 2+ -removal from the medium and 0.1 mM nifedipine, a voltage gated Ca 2+ -channel blocker (Figure 3b) . However, interestingly, the release of ATP was almost unaected by these procedures (Figure 3a) .
In a further study, in addition to a,b-mATP, the eects of other P2-agonists on both responses were examined in the tissue segments. The release of ATP was considerably enhanced by 100 mM UTP. However, the evoked release was virtually unaected by RB-2 at 30 mM. b,g-Methylene ATP (b,g-mATP) and ADP at 100 mM caused a moderate release of ATP (Figure 4a ). From these ®ndings, the potency order of the P2-agonists tested at releasing ATP was a,b-mATP4 UTP4b,g-mATP4ADP. On the other hand, unlike a,bmATP, neither UTP, b,g-mATP nor ADP elicited a measurable contraction of the ileal segments (Figure 4b) .
In perfused cultured smooth muscle cells from the ileum, a,b-mATP (100 mM) enhanced ATP release by approximately 5 fold from the basal release (Figure 5a ). The evoked release of ATP was notably reduced in the presence of 30 mM RB-2 ( Figure 5b ).
Discussion
For a long time a,b-mATP has been considered to be a typical P2X-purinoceptor agonist as it causes a contractile response in the mesenteric artery (Burnstock & Warland, 1987) and ear artery (Le et al., 1990) of rabbit and in the urinary bladder (Hoyle et al., 1990 ) of guinea-pig. However, several studies have suggested that a,b-mATP may also act as a weak agonist for P2Y-purinoceptors (Satchell & Maguire, 1975; Fredholm et al., 1994) . In the present study, the ileal longitudinal muscle segments of guinea-pig responded to 100 mM a,b-mATP with a contraction and ATP release. The release of ATP evoked by the P2-agonist seems to be dissimilar in characteristics from the evoked contraction on the basis of the concentration-response curve data and the time-course until a maximum response. Furthermore, the dependence on extracellular Ca 2+ between the contraction and ATP release was quite opposite, as seen from the dierent eects of Ca 2+ -removal and nifedipine on both responses. In addition, the contraction by the P2-agonist was sensitive to tetrodotoxin and atropine, whereas the release of ATP was insensitive to either blocker.
The contractile response to a,b-mATP was strongly antagonized by suramin, tetrodotoxin and atropine, but not by PPADS and RB-2, whereas the evoked release of ATP was suppressed by all of the P2-antagonists tested. So far, no speci®c antagonists for P2X, P2Y and P2U-purinoceptors have been found. It is well-documented that suramin shows antagonistic eects for P2Y as well as for P2X-receptors (Hoyle et al., 1990; Fredholm et al., 1994) . Another P2-receptor antagonist, RB-2 has been shown to exhibit relatively speci®c blockade of P2Y-purinoceptors in a narrow concentration range, e.g., 1 to 30 mM, at most 50 mM (Hoyle, 1992) . cells (NoÈ renberg et al., 1994) and megakaryocytes (Uneyama et al., 1994) from rat. Similarly, ATP-induced increase of dopamine in rat striatum was blocked by 20 mM RB-2 as well as by 1 mM suramin (Zhang et al., 1995) . From results with the vas deferens and urinary bladder, it has been suggested that PPADS is a selective P2X-purinoceptor antagonist (Lambrecht et al., 1992; Ziganshin et al., 1993; Usune et al., 1996) . However, there are marked tissue dierences in the blocking eects of PPADS for P2-receptor mediated-responses. In rat duodenum, relaxations evoked by 2-methylthio ATP, a P2Y-receptor agonist, and a,b-mATP were antagonized by PPADS (3 ± 30 mM) (Windscheif et al., 1995) . In bovine aortic endothelial cells, accumulation of [ 3 H]-inositol polyphosphate mediated by 2-methylthio ATP, but not by UTP, was markedly attenuated by 10 ± 30 mM PPADS (Brown et al., 1995) . In addition, 30 mM PPADS has been found to antagonize competitively the activation of phospholipase C by 2-methylthio ATP in turkey erythrocytes (Boyer et al., 1994) . Similarly, an increase of cytosolic Ca 2+ concentration by 2-methylthio ATP in myocytes isolated from rat ileal smooth muscles was notably inhibited by 5 to 10 mM PPADS (Pacaud et al., 1996) . These ®ndings provide evidence that PPADS acts as a P2Y-receptor antagonist as well as a P2X-receptor antagonist. Therefore the present ®ndings also suggest that PPADS, like RB-2, functions as, presumably, a P2Y-purinoceptor antagonist in this tissue. Unfortunately, we could not evaluate the eect of 2-methylthio ATP on ATP release because the agonist per se was highly reactive to luciferin-luciferase. However, the possibility that the release of ATP evoked by a,b-mATP may be mediated by P2Y-like purinoceptors is supported by a previous study showing that a,b-mATP causes an accumulation of inositol-1,4,5-trisphosphate together with ATP release in guinea-pig ileum .
Taken together, these results on the contractile response and the release of ATP evoked by a,b-mATP in the ileal longitudinal muscle segments are interpreted as follows: the contraction and the release of ATP may result from stimulation of P2X-like and P2Y-like purinoceptors, respectively. Since the evoked contraction was inhibited by tetrodotoxin and atropine, a,b-mATP seems to act, probably, on P2X-purinoceptors situated on cholinergic nerve endings and, subsequently, to release acetylcholine causing an atropine-sensitive contraction of the smooth muscles as shown previously (Moody & Burnstock, 1982; Sperlagh & Vizi, 1991; Kennedy & Humphrey, 1994) . The steepness of the concentration-contractile response curve for a,b-mATP indicates the characteristic depolarization by the P2-agonist of the cell membrane of cholinergic nerves. On the other hand, the evoked release of ATP was virtually unaected by tetrodotoxin and atropine. We have shown that 1 mM acetylcholine and 10 mM bethanechol are capable of causing ATP release from guinea-pig ileal segments (Katsuragi et al., 1990; 1992a) . The reason for the lack of eect of tetrodotoxin and atropine on the release of ATP may be that the endogeneous acetylcholine released by a,b-mATP is at an extremely low concentration compared to the 1 mM acetylcholine added exogenously in the studies mentioned above. The contractions elicited by P2-purinoceptor agonists are unlikely, at least, to be mediated by P2U-receptors because of the lack of a contractile response to 100 mM UTP. However, since the release of ATP induced by UTP was not aected by the presence of RB-2, the involvement of P2U-purinoceptors in causing ATP release from the ileum cannot be excluded. In general, either muscular or nervous tissue in the ileal segments seem likely as the origin of the evoked release of ATP. However, the ®nding that the release of ATP by a,b-mATP was virtually unaected by Ca 2+ -removal and nifedipine argues against the possibility of a neuronal origin. Also, in the perfusion study with the cultured ileal smooth muscle cells, the a,b-mATPelicited release of ATP was sensitive to RB-2. Accordingly, the purinoceptor-mediated release of ATP seems to come mainly from smooth muscle cells, at least, in the cultured cells. The physiological role of ATP release remains to be clari®ed in future investigations.
